| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 5.375 | 17.587 | 33.608 | 77.609 | 110.750 | 115.694 |
| Total Income - EUR | - | - | - | - | 5.375 | 17.587 | 33.608 | 79.571 | 110.750 | 115.694 |
| Total Expenses - EUR | - | - | - | - | 3.484 | 4.665 | 7.227 | 22.817 | 33.962 | 41.339 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.891 | 12.922 | 26.381 | 56.754 | 76.788 | 74.355 |
| Net Profit/Loss - EUR | - | - | - | - | 1.730 | 12.417 | 25.372 | 54.864 | 75.846 | 70.954 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nabmedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 538 | 449 | 356 | 264 |
| Current Assets | - | - | - | - | 3.331 | 16.052 | 39.110 | 55.087 | 91.893 | 93.203 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 2.966 | 0 | 22.317 | 50.042 | 68.820 | 71.137 |
| Cash | - | - | - | - | 365 | 16.052 | 16.793 | 5.045 | 23.073 | 22.066 |
| Shareholders Funds | - | - | - | - | 1.772 | 14.155 | 39.214 | 54.913 | 91.417 | 71.002 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.558 | 1.896 | 434 | 625 | 832 | 22.550 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nabmedica S.r.l.